JP2022501351A5 - - Google Patents
Info
- Publication number
- JP2022501351A5 JP2022501351A5 JP2021515106A JP2021515106A JP2022501351A5 JP 2022501351 A5 JP2022501351 A5 JP 2022501351A5 JP 2021515106 A JP2021515106 A JP 2021515106A JP 2021515106 A JP2021515106 A JP 2021515106A JP 2022501351 A5 JP2022501351 A5 JP 2022501351A5
- Authority
- JP
- Japan
- Prior art keywords
- crystalline form
- acryloylpiperidine
- phenoxyphenyl
- nicotinamide
- ray diffraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862732994P | 2018-09-18 | 2018-09-18 | |
| US62/732,994 | 2018-09-18 | ||
| PCT/CN2019/106433 WO2020057549A1 (en) | 2018-09-18 | 2019-09-18 | Crystalline forms of 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022501351A JP2022501351A (ja) | 2022-01-06 |
| JP2022501351A5 true JP2022501351A5 (https=) | 2022-09-12 |
Family
ID=69888278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021515106A Pending JP2022501351A (ja) | 2018-09-18 | 2019-09-18 | ６−（１−アクリロイルピペリジン−４−イル）−２−（４−フェノキシフェニル）ニコチンアミドの結晶形 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11945792B2 (https=) |
| EP (1) | EP3853217B1 (https=) |
| JP (1) | JP2022501351A (https=) |
| KR (1) | KR20210060501A (https=) |
| CN (2) | CN112654607B (https=) |
| AU (1) | AU2019341284B2 (https=) |
| CA (1) | CA3111114A1 (https=) |
| ES (1) | ES2951420T3 (https=) |
| MX (1) | MX2021003064A (https=) |
| SG (1) | SG11202102116XA (https=) |
| WO (1) | WO2020057549A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115894440B (zh) * | 2022-10-27 | 2024-10-22 | 都创(重庆)医药科技有限公司 | 奥布替尼化合物的晶型及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015028662A1 (en) | 2013-08-30 | 2015-03-05 | Consejo Superior De Investigaciones Cientificas (Csic) | Compositions and methods for characterization and amelioration of rheumatoid arthritis |
| KR102272792B1 (ko) * | 2013-09-30 | 2021-07-05 | 광저우 이노케어 파마 테크 씨오., 엘티디. | Ｂｔｋ의 치환된 니코틴이미드 저해제 및 그의 제조 방법 및 암, 염증 및 자가면역 질환에의 용도 |
| SG11201704808VA (en) * | 2014-12-18 | 2017-07-28 | Principia Biopharma Inc | Treatment of pemphigus |
| US20180193274A1 (en) * | 2014-12-24 | 2018-07-12 | Principia Biopharma Inc. | Compositions for ileo-jejunal drug delivery |
-
2019
- 2019-09-18 AU AU2019341284A patent/AU2019341284B2/en active Active
- 2019-09-18 KR KR1020217009903A patent/KR20210060501A/ko not_active Ceased
- 2019-09-18 ES ES19862150T patent/ES2951420T3/es active Active
- 2019-09-18 CN CN201980058360.8A patent/CN112654607B/zh active Active
- 2019-09-18 JP JP2021515106A patent/JP2022501351A/ja active Pending
- 2019-09-18 WO PCT/CN2019/106433 patent/WO2020057549A1/en not_active Ceased
- 2019-09-18 SG SG11202102116XA patent/SG11202102116XA/en unknown
- 2019-09-18 MX MX2021003064A patent/MX2021003064A/es unknown
- 2019-09-18 EP EP19862150.0A patent/EP3853217B1/en active Active
- 2019-09-18 CN CN202211635896.1A patent/CN116496247A/zh active Pending
- 2019-09-18 CA CA3111114A patent/CA3111114A1/en active Pending
-
2021
- 2021-03-03 US US17/191,310 patent/US11945792B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021530451A5 (https=) | ||
| FI2854859T3 (fi) | Brutonin tyrosiinikinaasin estäjän kiteisiä muotoja | |
| EP4169913A4 (en) | SUBSTITUTED PYRAZINE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | |
| GEP201706692B (en) | Biaryl amide compounds as kinase inhibitors | |
| JP2009538861A5 (https=) | ||
| JP2018158949A5 (https=) | ||
| JP2015193630A5 (https=) | ||
| PH12015501517A1 (en) | Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease | |
| RU2017143965A (ru) | Кристаллы флумиоксазина | |
| JP2012036197A5 (https=) | ||
| JP2019510768A5 (https=) | ||
| MX2013004190A (es) | Composiciones y metodos para el tratamiento de la hipertension pulmonar. | |
| WO2017160116A3 (ko) | 니코틴아미드 포스포리보실트랜스퍼라제 억제용 신규 화합물 및 이를 포함하는 조성물 | |
| WO2016126085A3 (ko) | 헤테로 고리 화합물 및 그를 포함하는 약제학적 조성물 | |
| JP2023553930A5 (https=) | ||
| WO2016196646A8 (en) | Cannabinoid receptor mediating compounds | |
| JP2015522037A5 (https=) | ||
| HK1212688A1 (zh) | 吡啶酮衍生物及其在治疗、改善或预防病毒疾病中的用途 | |
| IL273896B1 (en) | Crystalline forms of 1,2,4-oxadiazole-3-methyl-1,2-dione | |
| JP2022501351A5 (https=) | ||
| JP2022540353A5 (https=) | ||
| JP2009167413A5 (https=) | ||
| SG11202108863WA (en) | Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof | |
| JP2021520357A5 (https=) | ||
| WO2015002755A3 (en) | Compounds for the treatment of malaria |